BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen YY, Hsieh YC, Gong YN, Liao WC, Li SW, Chang IY, Lin TL, Huang CT, Chiu CH, Wu TL, Su LH, Li TH, Huang YY. Genomic Insight into the Spread of Meropenem-Resistant Streptococcus pneumoniae Spain23F-ST81, Taiwan. Emerg Infect Dis 2020;26:711-20. [PMID: 32186492 DOI: 10.3201/eid2604.190717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen YY, Huang CT, Li SW, Pan YJ, Lin TL, Huang YY, Li TH, Yang YC, Gong YN, Hsieh YC. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus. J Biomed Sci 2021;28:60. [PMID: 34452635 DOI: 10.1186/s12929-021-00756-0] [Reference Citation Analysis]
2 Taniguchi T, Tsuha S, Shiiki S, Narita M. Point-of-care cerebrospinal fluid Gram stain for the management of acute meningitis in adults: a retrospective observational study. Ann Clin Microbiol Antimicrob 2020;19:59. [PMID: 33287843 DOI: 10.1186/s12941-020-00404-9] [Reference Citation Analysis]
3 Kawaguchiya M, Urushibara N, Aung MS, Kudo K, Ito M, Habadera S, Kobayashi N. Genetic characterization of penicillin-binding proteins of nonencapsulated Streptococcus pneumoniae in the postpneumococcal conjugate vaccine era in Japan. Int J Infect Dis 2022;120:174-6. [PMID: 35470022 DOI: 10.1016/j.ijid.2022.04.033] [Reference Citation Analysis]
4 Chen C, Janapatla RP, Su L, Li H, Kuo K, Chien C, Hsiao C, Chiu C. Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.04.022] [Reference Citation Analysis]
5 Li L, Zhou J, Li M, Yu Z, Gao K, Yang J, Cheng P, Yang J, Zhang W, Yu Z, Sun H. Comparative Genomic Analysis of Streptococcus pneumoniae Strains: Penicillin Non-susceptible Multi-drug-Resistant Serotype 19A Isolates. Curr Microbiol 2022;79:49. [PMID: 34982234 DOI: 10.1007/s00284-021-02715-2] [Reference Citation Analysis]
6 Varghese R, Basu S, Neeravi A, Pragasam A, Aravind V, Gupta R, Miraclin A, Ramaiah S, Anbarasu A, Veeraraghavan B. Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges. Front Microbiol 2021;12:810414. [PMID: 35185834 DOI: 10.3389/fmicb.2021.810414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chien YC, Lee YL, Liu PY, Lu MC, Shao PL, Lu PL, Cheng SH, Lin CY, Wu TS, Yen MY, Wang LS, Liu CP, Lee WS, Shi ZY, Chen YS, Wang FD, Tseng SH, Chen YH, Sheng WH, Lee CM, Chen YH, Ko WC, Hsueh PR. National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020. J Glob Antimicrob Resist 2021;26:308-16. [PMID: 34289409 DOI: 10.1016/j.jgar.2021.07.005] [Reference Citation Analysis]